E
Lifecore Biomedical, Inc. LFCR
$6.38 $0.213.40% NASDAQ
Recommendation
Prev Close
$6.17
Volume
155,733
Avg Vol (90D)
247,016
Market Cap
$228.45M
Dividend & Yield
--
52-Week Range
$3.68 - $7.99
P/E (TTM)
--
EPS (TTM)
-$1.49
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Lifecore Biomedical (LFCR, $6.17) price exceeded its 50-day Moving Average on April 24, 2025
4/25/2025 - Tickeron - Technical Analysis
Lifecore Biomedical (LFCR, $6.18) price moved above its 50-day Moving Average on April 22, 2025
4/23/2025 - Tickeron - Technical Analysis
Lifecore Biomedical (LFCR, $6.04) price exceeded its 50-day Moving Average on April 21, 2025
4/22/2025 - Tickeron - Technical Analysis
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
4/22/2025 - GuruFocus
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference LFCR Stock News
4/22/2025 - GuruFocus
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
4/22/2025 - Globe Newswire
116,538 Shares in Lifecore Biomedical, Inc. (NASDAQ:LFCR) Acquired by Alpha Wave Global LP
4/20/2025 - MarketBeat
Lifecore Biomedical (LFCR, $6.41) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 17, 2025
4/18/2025 - Tickeron - Stocks
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/16/2025 - Globe Newswire
Lifecore Biomedical (LFCR, $6.17) price moved above its 50-day Moving Average on April 14, 2025
4/15/2025 - Tickeron - Technical Analysis
LifeCore Biomedical (LFCR) in Greenhaven Road Capital Q3 2024
4/14/2025 - GuruFocus
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer LFCR ...
4/14/2025 - GuruFocus
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
4/14/2025 - GuruFocus
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
4/14/2025 - Globe Newswire
Lifecore Biomedical (LFCR, $5.72) price exceeded its 50-day Moving Average on April 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Lifecore Biomedical (LFCR, $6.23) price moved above its 50-day Moving Average on April 09, 2025
4/10/2025 - Tickeron - Technical Analysis
Lifecore Biomedical (LFCR, $6.23) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Technical Analysis
Craig-Hallum Remains a Buy on Lifecore Biomedical (LFCR)
4/9/2025 - TipRanks Financial Blog
Add Up The Pieces: VTWV Could Be Worth $170
4/9/2025 - ETF Channel
Hedge funds owners may consider drastic measures as Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) recent US$65m drop adds to long-term losses
4/7/2025 - Simply Wall St
Lifecore Biomedical (LFCR, $5.29) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 4, 2025
4/5/2025 - Tickeron - Stocks
Lifecore Biomedical (LFCR, $5.29) price exceeded its 50-day Moving Average on April 04, 2025
4/5/2025 - Tickeron - Stocks
Lifecore Biomedical (LFCR, $5.29) RSI Indicator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Stocks
Lifecore Biomedical (NASDAQ:LFCR) Announces Earnings Results, Misses Estimates By $0.05 EPS
4/5/2025 - MarketBeat
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
4/5/2025 - Insider Monkey
Income Statement
Total Revenue (TTM)
$130.31M
EBITDA (TTM)
-$2.18M
EBIT (TTM)
-$10.05M
Net Income (TTM)
-$44.65M
Balance Sheet
Total Assets (Q)
$237.69M
Total Debt (Q)
$130.34M
Total Liabilities (Q)
$190.27M
Book Value Per Share (Q)
$0.0602
Cash Flow
Cash from Operations (TTM)
$3.09M
Cash from Investing (TTM)
-$6.96M
Cash from Financing (TTM)
$6.21M
Net Change in Cash (TTM)
$2.34M
Filings
Filing Date
Thursday, April 3, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.57
7-Day Total Return
2.08%
30-Day Total Return
0.31%
60-Day Total Return
5.45%
90-Day Total Return
-15.83%
Year to Date Total Return
-4.20%
1-Year Total Return
-3.92%
2-Year Total Return
45.66%
3-Year Total Return
-37.08%
5-Year Total Return
-41.25%
52-week Low
Aug 29, 2024 - $3.68
52-week High
Nov 21, 2024 - $7.99
Valuation
Market Cap
$228.45M - Micro Cap
Enterprise Value
$398.57M
Price/Sales (TTM)
1.75
Price/Book (Q)
102.49
Dividends and Shares
Shares Outstanding
37.02M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lifecore.com
Phone Number
(952) 368-4300
Address
3515 Lyman Boulevard
Chaska, MN 55318
Country
United States
Year Founded
1965
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed